Stay updated with breaking news from Mood Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Chris Wack Anavex Life Sciences shares were down 30% to $6.50 after the company said its Anavex 2-73 study missed a primary endpoint. The clinical-stage...
The initiative, facilitated in Bairnsdale, aims to help identify mums at risk of perinatal anxiety and depression.
*Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel in patients with Fragile X syndrome; topline results expected first-half 2024 *$44.4 million in cash and cash... | May 16, 2023
Zygel continued to be well-tolerated with long-term administration and maintained clinically meaningful improvements in children and adolescents with Fragile X syndrome Zygel achieved statistically... | April 13, 2023
Zygel continued to be well-tolerated with long-term administration and maintained clinically meaningful improvements in children and adolescents with Fragile X syndrome Zygel achieved statistically... | April 12, 2023